Dr Reddy’s wins Health Canada approval for generic semaglutide injection first in Canada

Published on 29 April 2026

First approval for this diabetes drug in Canada

Dr Reddy’s Laboratories has received market authorization from Health Canada for its generic semaglutide injection, becoming the first company approved for the diabetes therapy in Canada. The Bengaluru-based pharma is now preparing a launch to expand access for patients who rely on the treatment, potentially easing pressure on medication availability and costs.

Health Canada has authorized Dr Reddy’s generic semaglutide injection
It is the first approval of this diabetes treatment in Canada
Dr Reddy’s is preparing to launch the medication for patients
The move could improve access to a widely used therapy

#health canada #diabetes #generic drugs #semaglutide #dr reddys

Read the full story at The Economic Times

This summarization was done by Beige for a story published on The Economic Times

Dr Reddy’s wins Health Canada approval for generic semaglutide injection first in Canada

The full experience is on mobile.